Literature DB >> 34165679

Comparing different markers of tubular dysfunction in transfusion-dependent thalassemia patients.

Ilham Youssry1, Samuel Makar1, Khalil Abdelkhalek1, Dina Hisham2, Happy Sawires3.   

Abstract

BACKGROUND: Renal tubular dysfunction was reported in transfusion-dependent thalassemia (TDT) patients and ranges from mild to severe. The objectives of our study were identification of the best marker of early renal tubular dysfunction in TDT patients among the three most commonly used urinary biomarkers, named neutrophil gelatinase-associated lipocalin (NGAL), retinol-binding protein (RBP) and N-acetyl-D-glucosaminidase (NAG) and correlation of these biomarkers with different patient variables.
METHODOLOGY: Sixty-one TDT patients and another 62 healthy children were enrolled in a cross-sectional study. Morning urine samples were taken for measurement of calcium, phosphorus, creatinine, microalbumin and markers of tubular dysfunction (NGAL, NAG and RBP). Urine NGAL/creatinine (UrNGAL/Cr), urine NAG/creatinine (UrNAG/Cr) and urine RBP/creatinine (UrRBP/Cr) ratios were used for accuracy. Patients were classified into 2 groups: group A, with tubular dysfunction and group b, without tubular dysfunction.
RESULTS: Group A showed statistically significant higher UrNGAL/Cr (p < 0.001), UrRBP/Cr (p < 0.001) and UrNAG/Cr (p <0.001) than group B. In group A, microalbuminuria was detected only in 7 patients (28%) while it was detected in 12 patients (33.3%) in group B. By using ROC curve analysis, the diagnostic cutoff values for UrNGAL/Cr, UrRBP/Cr and UrNAG/Cr were 3713.38, 1614.85 and 56.56 ng/g, respectively. We found a statistically significant superiority of UrNGAL/Cr over UrRBP/Cr (p < 0.001) and UrRBP/Cr over UrNAG/Cr (p < 0.001).
CONCLUSION: Evaluation of UrNGAL/Cr, UrRBP/Cr and UrNAG/Cr could early discriminate tubular dysfunction TDT patients from those with normal tubular function. UrNGAL/Cr is more accurate in early detection of tubular dysfunction when compared with the other two biomarkers.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  NAG; NGAL; RBP; Transfusion-dependent thalassemia; Tubular dysfunction

Mesh:

Substances:

Year:  2021        PMID: 34165679     DOI: 10.1007/s11255-021-02914-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  24 in total

1.  Renal function in pediatric patients with beta-thalassemia major.

Authors:  B Aldudak; A Karabay Bayazit; A Noyan; A Ozel; A Anarat; I Sasmaz; Y Kilinç; E Gali; R Anarat; N Dikmen
Journal:  Pediatr Nephrol       Date:  2000-11       Impact factor: 3.714

2.  Renal function in transfusion-dependent pediatric beta-thalassemia major patients.

Authors:  Amir Jalali; Hamid Khalilian; Ali Ahmadzadeh; Somie Sarvestani; Fakher Rahim; Khodamorad Zandian; Shideh Asar
Journal:  Hematology       Date:  2011-07       Impact factor: 2.269

3.  Kidney Function in Patients With Different Variants of Beta-Thalassemia.

Authors:  Azar Nickavar; Azadeh Qmarsi; Shahla Ansari; Elham Zarei
Journal:  Iran J Kidney Dis       Date:  2017-03       Impact factor: 0.892

4.  Renal dysfunction in patients with beta-thalassemia major receiving iron chelation therapy either with deferoxamine and deferiprone or with deferasirox.

Authors:  Marina Economou; Nikoletta Printza; Aikaterini Teli; Vassiliki Tzimouli; Ioanna Tsatra; Fotis Papachristou; Miranda Athanassiou-Metaxa
Journal:  Acta Haematol       Date:  2010-02-24       Impact factor: 2.195

5.  Urine biochemical markers of early renal dysfunction are associated with iron overload in beta-thalassaemia.

Authors:  G Koliakos; F Papachristou; A Koussi; V Perifanis; I Tsatra; E Souliou; M Athanasiou
Journal:  Clin Lab Haematol       Date:  2003-04

6.  Early markers of renal dysfunction in patients with beta-thalassemia major.

Authors:  Masoumeh Mohkam; Bibi Shahin Shamsian; Atoosa Gharib; Shahin Nariman; Mohammad T Arzanian
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

7.  Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study.

Authors:  Enas A Hamed; Nagla T ElMelegy
Journal:  Ital J Pediatr       Date:  2010-05-25       Impact factor: 2.638

8.  Renal function in children with beta-thalassemia major and thalassemia intermedia.

Authors:  Vladislav Smolkin; Raphael Halevy; Carina Levin; Miguel Mines; Waheeb Sakran; Katzap Ilia; Ariel Koren
Journal:  Pediatr Nephrol       Date:  2008-06-25       Impact factor: 3.714

9.  Early Predictors of Renal Dysfunction in Egyptian Patients with β-Thalassemia Major and Intermedia.

Authors:  Azza A G Tantawy; Nagham El Bablawy; Amira A M Adly; Fatma S E Ebeid
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-09-01       Impact factor: 2.576

10.  Glomerular and Tubular Functions in Children and Adults with Transfusion-Dependent Thalassemia.

Authors:  Agageldi Annayev; Zeynep Karakaş; Serap Karaman; Altan Yalçıner; Alev Yılmaz; Sevinç Emre
Journal:  Turk J Haematol       Date:  2017-07-28       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.